Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • META vs MRNA✓SelectedUSD · MRNAMETA vs MRNA performance historyLatest closeAs of-0.40%11/18
Stock and ETF performance explorer

META vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+83.7%
MRNA return
-20.0%
Excess return
+103.8%
Maximum drawdown
-74.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.4%-4.8%+4.4%-0.1%
7D-2.0%-20.9%+18.9%-0.6%
30D-12.6%-13.3%+0.6%-12.0%
3M+13.5%+212.6%-199.1%+0.8%
6M+1.0%+309.0%-308.0%-14.8%
YTD-6.4%+567.3%-573.7%-27.7%
1Y+3.5%+689.7%-686.2%-22.5%
3Y+85.7%+157.4%-71.7%+52.8%
5Y+83.7%-21.7%+105.5%+74.8%
All+83.7%-20.0%+103.8%+74.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling